According to a new report by Univdatos Market Insights, the Inflammatory Bowel Disease Market is expected to reach USD 32 Billion in 2032 by growing at a CAGR of ~5%. Inflammatory bowel disease (IBD) comprises a group of chronic inflammatory conditions of the gastrointestinal tract, primarily including Crohn's disease and ulcerative colitis. These conditions result from an abnormal immune...